Sante Ventures
201 W 5th StreetAustin, TX 78701
Website: sante.com
Firm Size
- Assets Under Management (AUM):$977 Million
- Number of Funds:7
- Employees:
- Firm Type:Venture Capital
- Focus Areas:
Software & Technology
Services
Healthcare
Description
Sante Ventures is a venture capital firm based in Austin, Texas, specializing in healthcare and life sciences investments. With a focus on early-stage investments, Sante Ventures aims to support innovative companies within the healthcare industry that have the potential to make a significant impact in patient care and outcomes. The firm actively seeks out entrepreneurs and startups with disruptive technologies and business models that address critical healthcare needs. Sante Ventures provides capital, strategic guidance, and industry expertise to help these companies navigate challenges and accelerate their growth. Sante Ventures' investment portfolio spans various sectors within healthcare, including biotechnology, medical devices, diagnostics, digital health, and healthcare services. They prioritize companies that have demonstrated substantial market potential and possess a strong scientific foundation, which are essential factors for driving successful commercialization. Headed by a team of seasoned investors and experienced industry professionals, Sante Ventures brings decades of collective expertise to its investment decisions. The firm's partners actively participate in the companies they invest in, leveraging their networks and knowledge to foster growth and create value. Located in Austin, Texas, Sante Ventures benefits from the city's thriving healthcare and technology ecosystem, which offers a diverse pool of talent, research institutions, and industry partners. This positioning allows the firm to stay at the forefront of emerging trends and connect its portfolio companies with valuable resources and opportunities. In summary, Sante Ventures is a respected venture capital firm in Austin, Texas, known for its focus on healthcare and life sciences investments. By backing early-stage companies with transformative technologies, Sante Ventures plays a crucial role in driving innovation and improving patient care within the healthcare industry.Latest News
Powered by
Dec 07, 2023: A Deep Dive into the Inherent Scale Limitations of Venture Capital Performance with Increasing Fund Size
Santé Ventures , (Santé), an early-stage healthcare and life sciences investment firm, shared updated research on venture capital fund performance and the level of correlation with fund size. While large funds offer presumed advantages of scale, brand recognition, and experience, data show that these benefits do not scale accordingly. This comes at a time when the total venture capital raised by sizeable individual funds has increased fourfold from 2012-2022 compared to 1990-2011 – providing a cautionary tale for limited partners in their alternative investment allocations.
Nov 30, 2023: Laminar, Inc. Acquired by Johnson & Johnson Medtech for $400 Million Upfront with Additional Clinical and Regulatory Milestone Payments in 2024 and Beyond
Santé Ventures (Santé), an early-stage healthcare and life sciences investment firm, has announced the acquisition of its Fund III portfolio company, Laminar, Inc., by Johnson & Johnson Medtech. The purchase was completed with an upfront payment of $400 million and additional clinical and regulatory milestone payments expected in 2024 and beyond. As Laminar's sole venture capital investor, Santé played an essential role in helping develop the company's novel approach to eliminating the left atrial appendage (LAA) in patients with non-valvular AFib. Laminar will join Johnson & Johnson MedTech as part of Biosense Webster, Inc. – a global leader in cardiac arrhythmia treatment.
Sep 06, 2023: Santé Ventures Announces Promotions for Auriel August, MD and Michael Gutbrod, PhD
Santé Ventures , (Santé), an early-stage healthcare and life sciences investment firm, has announced promotions for two members of the investment team. Auriel August , MD, has been promoted to Principal, and Michael Gutbrod , PhD to Senior Associate. Both joined the firm in 2021 and have made meaningful contributions in identifying and managing portfolio company investments.
May 09, 2023: Healthcare Highways Announces Addition of New Board Members Jack Martin and Carlos Zaffirini as Company Expands Already Strong Partnerships in Austin Community
Healthcare Highways today announced the addition of Jack Martin , the founder of Public Strategies, Inc., and Carlos Zaffirini, the President of Adelanto Healthcare Ventures (AHCV), to its board of directors as the company continues to expand its already strong partnerships in the Austin community. Martin and Zaffirini will serve on the Healthcare Highways board of directors alongside other prominent Texas leaders, including Pro Football Hall of Famer Emmitt Smith and Austin -based Santé Ventures founding partners Doug French and Dr. Joe Cunningham .
May 04, 2023: Surgical Safety Technologies Furthers its Mission of Improving Operating Room Safety and Efficiency With $15 Million in Series A Funding
Surgical Safety Technologies (SST), a medical technology company that engineered the OR Black Box ® platform for hospitals, has today announced $15 Million in Series A funding. The round was led by U.S. Venture Partners and Santé Ventures , and will be used to accelerate the company's automation initiatives and commercial efforts. SST's platform leverages AI both to inform real-time decision making and provide analytical insight in the areas of safety, compliance and efficiency, which drastically improves patient outcomes and reduces hospital costs.